Financial Year |
March 31 2023 |
Monetary Funds |
851,210,803.87 |
Held-for-trading Financial Assets |
848,469,242.66 |
Notes Receivable |
82,809,549.82 |
Accounts Receivable |
450,427,651.02 |
Advances to Suppliers |
10,476,997.10 |
Other Receivables |
373,710,090.05 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
405,120,714.21 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
43,043,399.85 |
Total Current Assets |
3,075,201,836.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
14,256,077.62 |
Fixed Assetes |
290,794,609.51 |
Under-construction Projects |
9,846,821.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
32,364,428.26 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
340,144.57 |
Deferred Income Tax Assets |
18,886,547.53 |
Other Non-Current Assets |
68,093,486.15 |
Sub-Total of Non-Current Assets |
460,145,357.05 |
Total Assets |
3,535,347,193.13 |
Short-Term Loans |
20,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
288,628,761.09 |
Accounts Payable |
300,142,156.47 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
40,123,314.03 |
Taxes Payable |
19,921,528.06 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
12,700,130.03 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,446,513.08 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
694,792,085.52 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
522,710.37 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
48,303,442.85 |
Total Liabilities |
743,095,528.37 |
Paid-In Capital(Or Share Stock) |
402,056,966.00 |
Capital Surplus |
1,311,614,865.32 |
Surplus Reserve |
127,733,181.55 |
LESS:Treasury Stock |
30,985,217.53 |
Undistributed Profits |
973,108,664.35 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,792,251,664.76 |
Owner's Equity(Stockholder's Equity) |
2,792,251,664.76 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,535,347,193.13 |